BioSpace News Archive

Modular Medical, Inc. today announced the premarket submission of its MODD1 next-generation insulin pump to the FDA for 510(k) clearance.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2023 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, Feb. 1.

Venus Concept, Inc. announced today that it has issued new secured convertible notes to EW Healthcare Partners, L.P. and one of its affiliates (“EW Healthcare”) in an aggregate principal amount of $2.0 million.

Extendicare Inc. announced today that it plans to release its financial results for the fourth quarter of 2023 after market close on Thursday, March 7, 2024.

Oryzon Genomics, S.A. today announced that it will host a virtual KOL event on Thursday, January 25, 2024 at 10:00 am ET to briefly review, then discuss the topline results from the Phase IIb PORTICO study evaluating vafidemstat in Borderline Personality Disorder (BPD).

Vaxart, Inc. (Nasdaq: VXRT) today announced that the United States Biomedical Advanced Research and Development Authority (BARDA) has awarded the Company $9.27 million to fund preparation for a 10,000 subject Phase 2b clinical study evaluating Vaxart’s oral pill XBB COVID-19 vaccine candidate against an approved mRNA vaccine comparator.

Edgewise Therapeutics, Inc. today announced the pricing of an underwritten offering of 21,818,182 shares of its common stock at an offering price of $11.00 per share.

CARsgen Therapeutics Holdings Limited announces that at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (“ASCO GI”).

Prilenia Therapeutics B.V. will present clinical data supporting a future Phase 3 study in amyotrophic lateral sclerosis (ALS) during the 14th Annual California ALS Research Summit in Los Angeles.

Ventra Health (“Ventra”), a leading business solutions provider for facility-based physicians, announced today that it has named Mark Laperouse, M.D. as a Strategic Advisor for Emergency Medicine.